{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T08:33:50Z","timestamp":1795163630128,"version":"4.10.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Severe viral infections can disrupt host immunity and increase susceptibility to secondary pathogens. Experimental and preclinical studies suggest that severe viral pneumonia may also trigger reactivation of\n                    <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                    infection, yet population-level evidence remains limited. We conducted a nationwide retrospective cohort study in Chile, including more than 3.6 million adults with confirmed SARS-CoV-2 infection, to assess the risk of incident tuberculosis during follow-up. Individuals who developed severe COVID-19 requiring hospitalization had more than an eightfold higher hazard of tuberculosis within one year compared with those with non-severe disease. SARS-CoV-2 vaccination modified this association: the excess risk was substantially greater among unvaccinated individuals, whereas prior vaccination attenuated it. These findings indicate that severe COVID-19 is associated with an increased short- and long-term risk of tuberculosis and support the integration of targeted tuberculosis screening and preventive strategies into post-COVID-19 care, particularly among patients with severe disease.\n                  <\/jats:p>","DOI":"10.1038\/s41467-026-74528-5","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T18:34:27Z","timestamp":1782758067000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Risk of incident tuberculosis after severe COVID-19: a nationwide cohort study"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1277-0232","authenticated-orcid":false,"given":"Salvador","family":"Vargas-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5262-1157","authenticated-orcid":false,"given":"Lourdes","family":"Garc\u00eda-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Vergara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Escobar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9603-937X","authenticated-orcid":false,"given":"Luis A.","family":"Villarroel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasim","family":"Allel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4425-1253","authenticated-orcid":false,"given":"Eduardo A.","family":"Undurraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7223-9665","authenticated-orcid":false,"given":"Mar\u00eda Elvira","family":"Balcells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"74528_CR1","unstructured":"World Health Organization. Global tuberculosis report 2025 (World Health Organization, 2025)."},{"key":"74528_CR2","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S1473-3099(20)30124-9","volume":"20","author":"Y Su","year":"2020","unstructured":"Su, Y. et al. Tracking total spending on tuberculosis by source and function in 135 low-income and middle-income countries, 2000\u201317: a financial modelling study. Lancet Infect. Dis. 20, 929\u2013942 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"74528_CR3","doi-asserted-by":"publisher","first-page":"e1372","DOI":"10.1016\/S2214-109X(21)00299-0","volume":"9","author":"S Silva","year":"2021","unstructured":"Silva, S., Arinaminpathy, N., Atun, R., Goosby, E. & Reid, M. Economic impact of tuberculosis mortality in 120 countries and the cost of not achieving the Sustainable Development Goals tuberculosis targets: a full-income analysis. Lancet Glob. Health 9, e1372\u2013e1379 (2021).","journal-title":"Lancet Glob. Health"},{"key":"74528_CR4","unstructured":"GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 403, 2100\u20132132 (2024)."},{"key":"74528_CR5","unstructured":"World Health Organization. Global tuberculosis report 2024. (World Health Organization, 2024)."},{"key":"74528_CR6","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.jinf.2020.03.041","volume":"80","author":"L Fu","year":"2020","unstructured":"Fu, L. et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis. J. Infect. 80, 656\u2013665 (2020).","journal-title":"J. Infect."},{"key":"74528_CR7","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41423-023-01104-y","volume":"21","author":"BL Sievers","year":"2024","unstructured":"Sievers, B. L., Cheng, M. T. K., Csiba, K., Meng, B. & Gupta, R. K. SARS-CoV-2 and innate immunity: the good, the bad, and the \u201cgoldilocks\u201d. Cell Mol. Immunol. 21, 171\u2013183 (2024).","journal-title":"Cell Mol. Immunol."},{"key":"74528_CR8","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41590-021-01113-x","volume":"23","author":"C Phetsouphanh","year":"2022","unstructured":"Phetsouphanh, C. et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 23, 210\u2013216 (2022).","journal-title":"Nat. Immunol."},{"key":"74528_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41586-021-03553-9","volume":"594","author":"Z Al-Aly","year":"2021","unstructured":"Al-Aly, Z., Xie, Y. & Bowe, B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature 594, 259\u2013264 (2021).","journal-title":"Nature"},{"key":"74528_CR10","doi-asserted-by":"publisher","first-page":"102588","DOI":"10.1016\/j.eclinm.2024.102588","volume":"71","author":"N Glover","year":"2024","unstructured":"Glover, N. et al. Lung outcomes and related risk factors in patients after SARS-CoV-2 infection: a hospitalised single-centre cohort from Johannesburg, South Africa. eClinicalMedicine 71, 102588 (2024).","journal-title":"eClinicalMedicine"},{"key":"74528_CR11","doi-asserted-by":"publisher","first-page":"e0277807","DOI":"10.1371\/journal.pone.0277807","volume":"17","author":"A Alemu","year":"2022","unstructured":"Alemu, A. et al. Tuberculosis in individuals who recovered from COVID-19: A systematic review of case reports. PLoS ONE 17, e0277807 (2022).","journal-title":"PLoS ONE"},{"key":"74528_CR12","doi-asserted-by":"crossref","unstructured":"Kumwichar, P. & Chongsuvivatwong, V. COVID-19 pneumonia and the subsequent risk of getting active pulmonary tuberculosis: a population-based dynamic cohort study using national insurance claims databases. EClinicalMedicine 56, 101825 (2023).","DOI":"10.1016\/j.eclinm.2023.101825"},{"key":"74528_CR13","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.it.2024.07.008","volume":"45","author":"F Darboe","year":"2024","unstructured":"Darboe, F., Reijneveld, J. F., Maison, D. P., Martinez, L. & Suliman, S. Unmasking the hidden impact of viruses on tuberculosis risk. Trends Immunol. 45, 649\u2013661 (2024).","journal-title":"Trends Immunol."},{"key":"74528_CR14","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.jmii.2024.04.003","volume":"57","author":"J Lee","year":"2024","unstructured":"Lee, J., Seo, H., Kim, D., Hwang, J. & Kwon, J. W. Influenza and the risk of active tuberculosis occurrence among individuals with latent tuberculosis infection: a national cohort study in South Korea (2015\u20132020). J. Microbiol Immunol. Infect. 57, 437\u2013445 (2024).","journal-title":"J. Microbiol Immunol. Infect."},{"key":"74528_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.583897","volume":"7","author":"LM Kimmig","year":"2020","unstructured":"Kimmig, L. M. et al. IL-6 inhibition in critically Ill COVID-19 patients is associated with increased secondary infections. Front Med. 7, 583897 (2020).","journal-title":"Front Med"},{"key":"74528_CR16","doi-asserted-by":"publisher","first-page":"936","DOI":"10.5588\/ijtld.15.0031","volume":"19","author":"C-C Lai","year":"2015","unstructured":"Lai, C.-C., Lee, M.-T. G., Lee, S.-H., Chang, S.-S. & Lee, C.-C. Risk of incident active tuberculosis and use of corticosteroids. Int J. Tuberc. Lung Dis. 19, 936\u2013942 (2015).","journal-title":"Int J. Tuberc. Lung Dis."},{"key":"74528_CR17","doi-asserted-by":"publisher","first-page":"1900655","DOI":"10.1183\/13993003.00655-2019","volume":"54","author":"A Cohen","year":"2019","unstructured":"Cohen, A., Mathiasen, V. D., Sch\u00f6n, T. & Wejse, C. The global prevalence of latent tuberculosis: a systematic review and meta-analysis. Eur. Respir. J. 54, 1900655 (2019).","journal-title":"Eur. Respir. J."},{"key":"74528_CR18","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.ajpath.2021.03.011","volume":"191","author":"L Pathak","year":"2021","unstructured":"Pathak, L. et al. Coronavirus activates an altruistic stem cell-mediated defense mechanism that reactivates dormant tuberculosis: implications in coronavirus disease 2019 pandemic. Am. J. Pathol. 191, 1255\u20131268 (2021).","journal-title":"Am. J. Pathol."},{"key":"74528_CR19","doi-asserted-by":"publisher","first-page":"16315","DOI":"10.3390\/ijms242216315","volume":"24","author":"GS Shepelkova","year":"2023","unstructured":"Shepelkova, G. S. et al. Lung inflammation signature in post-COVID-19 TB patients. Int. J. Mol. Sci. 24, 16315 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"74528_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2017.03.008","volume":"83","author":"K Chen","year":"2017","unstructured":"Chen, K., Liu, J. & Cao, X. Regulation of type I interferon signaling in immunity and inflammation: a comprehensive review. J. Autoimmun. 83, 1\u201311 (2017).","journal-title":"J. Autoimmun."},{"key":"74528_CR21","doi-asserted-by":"publisher","first-page":"5536","DOI":"10.1016\/j.cell.2023.11.002","volume":"186","author":"DI Kotov","year":"2023","unstructured":"Kotov, D. I. et al. Early cellular mechanisms of type I interferon-driven susceptibility to tuberculosis. Cell 186, 5536\u20135553.e22 (2023).","journal-title":"Cell"},{"key":"74528_CR22","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3201\/eid2403.152071","volume":"24","author":"YF Yen","year":"2018","unstructured":"Yen, Y. F. et al. Influenza vaccination and incident tuberculosis among elderly persons, Taiwan. Emerg. Infect. Dis. 24, 498\u2013505 (2018).","journal-title":"Emerg. Infect. Dis."},{"key":"74528_CR23","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.3389\/fimmu.2019.02631","volume":"10","author":"B Agrawal","year":"2019","unstructured":"Agrawal, B. Heterologous Immunity: role in Natural and Vaccine-Induced Resistance to Infections. Front Immunol. 10, 2631 (2019).","journal-title":"Front Immunol."},{"key":"74528_CR24","unstructured":"Tobin, E. H. & Tristram, D. Tuberculosis. (StatPearls Publishing, 2024)."},{"key":"74528_CR25","doi-asserted-by":"publisher","unstructured":"Esmail, H. et al. High-resolution imaging and five-year tuberculosis contact outcomes. medRxiv https:\/\/doi.org\/10.1101\/2023.07.03.23292111 (2023).","DOI":"10.1101\/2023.07.03.23292111"},{"key":"74528_CR26","unstructured":"World Health Organization. Global tuberculosis report 2022 (World Health Organization, 2022)."},{"key":"74528_CR27","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"RECOVERY Collaborative Group.","year":"2021","unstructured":"RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with covid-19. N. Engl. J. Med. 384, 693\u2013704 (2021).","journal-title":"N. Engl. J. Med"},{"key":"74528_CR28","doi-asserted-by":"publisher","first-page":"2001348","DOI":"10.1183\/13993003.01348-2020","volume":"56","author":"MJ Saunders","year":"2020","unstructured":"Saunders, M. J. & Evans, C. A. COVID-19, tuberculosis and poverty: preventing a perfect storm. Eur. Respir. J. 56, 2001348 (2020).","journal-title":"Eur. Respir. J."},{"key":"74528_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-10244-z","volume":"24","author":"LE Calles-Cabanillas","year":"2024","unstructured":"Calles-Cabanillas, L. E. et al. Interaction between type 2 diabetes and past COVID-19 on active tuberculosis. BMC Infect. Dis. 24, 1383 (2024).","journal-title":"BMC Infect. Dis."},{"key":"74528_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02656-y","volume":"20","author":"T Zhang","year":"2022","unstructured":"Zhang, T. et al. Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis. BMC Med. 20, 444 (2022).","journal-title":"BMC Med"},{"key":"74528_CR31","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1136\/jech.2010.119933","volume":"65","author":"H Sch\u00fcnemann","year":"2011","unstructured":"Sch\u00fcnemann, H., Hill, S., Guyatt, G., Akl, E. A. & Ahmed, F. The GRADE approach and Bradford Hill\u2019s criteria for causation. J. Epidemiol. Community Health 65, 392\u2013395 (2011).","journal-title":"J. Epidemiol. Community Health"},{"key":"74528_CR32","first-page":"1401","volume":"19","author":"B Casetta","year":"2017","unstructured":"Casetta, B. et al. Association between cigarette smoking prevalence and income level: a systematic review and meta-analysis. Nicotine Tob. Res. 19, 1401\u20131407 (2017).","journal-title":"Nicotine Tob. Res"},{"key":"74528_CR33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1177\/17579759211067562","volume":"29","author":"A Blukacz","year":"2022","unstructured":"Blukacz, A., Cabieses, B., Mezones-Holgu\u00edn, E. & Cardona Arias, J. M. Healthcare and social needs of international migrants during the COVID-19 pandemic in Latin America: analysis of the Chilean case. Glob. Health Promot 29, 119\u2013128 (2022).","journal-title":"Glob. Health Promot"},{"key":"74528_CR34","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1038\/s41591-022-02051-3","volume":"28","author":"B Bowe","year":"2022","unstructured":"Bowe, B., Xie, Y. & Al-Aly, Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat. Med. 28, 2398\u20132405 (2022).","journal-title":"Nat. Med"},{"key":"74528_CR35","unstructured":"Ministerio de Salud de Chile. Manual para el uso del sistema GeneXpert MTB\/RIF. (Ministerio de Salud de Chile, 2018)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74528-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74528-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74528-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T22:54:14Z","timestamp":1786402454000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74528-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["74528"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-74528-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"2 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that the research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"8124"}}